Drugs / Anaerobically Cultivated Human Intestinal Microbiota
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02301000 | Feb 2015 → Nov 2017 | Clostridium difficile colitis | Oslo University Hospital | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03444220 Comparator | Jan → May 2018 | systemic sclerosis | Oslo University Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anaerobically cultivated human intestinal microbiota | “Anaerobically cultivated human intestinal microbiota” NCT02301000 ↗ |
| Known as | Intestinal Microbiota Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02301000 ↗ |
| Modality | Other / unclassified | “standardized, cultivated gut microbiome transplantation (GMT)” NCT03444220 ↗ |
| Route | Rectal | “60 ml of ACHIM suspension will be administered through a rectal tube” NCT02301000 ↗ |